MedTrace Logo

Organoid Model Predictive of Response to Immunotherapies

NCT06084676 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-07-17

No results posted yet for this study

Summary

The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validate this process and to predict responses to therapies and use it to choose the best treatments for people in the future. The researchers will then examine the direct effects of the treatment on those models.

Conditions

Interventions

DRUG

Immunotherapy

Organoid samples will be collected at time of biopsy and cultured in the lab. The samples will then receive the same standard of care immunotherapy treatment as the patient.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Mateusz Opyrchal, MD · Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2024-02-26
Completion
2024-02-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06084676 on ClinicalTrials.gov